It is commonly used in laboratory environments where a preserved aqueous solution is required for general solution preparation and research handling
In some embodiments, the lipid-based drug delivery formulation is a phospholipid-based formulation (e.g., hydrogenated or nonhydrogenated phospholipids, lecithins, phosphatidyl cholines (C8-C18), phosphatidylethanolamines (C8-C18), phosphatidylglycerols (C8-C18)) wherein the phospholipid is phospholipon 90H (1,2-dia-cyl-SN-glycero-3-phosphatidyl choline), egg phospholipids P123, Lipoid E80
If results remain strong and the FDA review process proceeds on schedule, approval could occur sometime between 2026 and 2027
These medications typically come in pre-filled, single-dose auto-injector pens
Vigorous shaking can denature the peptide and introduce air
Look at stimulants first